Stanford, CA5 Active Studies

Essential Tremor Clinical Trials in Stanford, CA

Find 5 actively recruiting essential tremor clinical trials in Stanford, CA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
1,782
Enrolling

Recruiting Essential Tremor Studies in Stanford

RecruitingStanford, CANCT04064060

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

A Phase 3b, open-label, single-arm, rollover study to evaluate the long-term safety of luspatercept, to the following participants: * Participants receiving luspatercept on a parent protocol at the t...

665 participants
Celgene
View Study Details
RecruitingStanford, CANCT06563895

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a sticky plaque- like substance that accumulates in different orga...

582 participants
Eidos Therapeutics, a BridgeBio company
View Study Details
RecruitingStanford, CANCT05443126

A Study of EP0031 in Patients With Advanced RET-altered Malignancies

The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies (NSCLC)...

265 participants
Ellipses Pharma
View Study Details
RecruitingStanford, CANCT06217302

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Wheth...

150 participants
Alessandro Doria
View Study Details
RecruitingStanford, CANCT06418880

Automated Insulin Delivery for Inpatients With Dysglycemia

This randomized controlled trial will test the efficacy and safety of automated insulin delivery (AID) in hospitalized patients with diabetes (type 1 or type 2) requiring insulin therapy who are admit...

120 participants
Emory University
View Study Details

About Essential Tremor Clinical Trials in Stanford

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 5 essential tremor clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 1,782 participants. Research is being sponsored by Celgene, Eidos Therapeutics, a BridgeBio company, Ellipses Pharma and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in Stanford — FAQ

Are there essential tremor clinical trials in Stanford?

Yes, there are 5 essential tremor clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Stanford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.

Are clinical trials in Stanford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 5 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated March 2, 2026 from ClinicalTrials.gov